Are you Dr. Haqq?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 9 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2100 Erwin Rd
Durham, NC 27710Phone+1 919-620-4467- Is this information wrong?
Summary
- Dr. Andrea Haqq, MD is an endocrinologist in Durham, North Carolina.
Education & Training
- Oregon Health & Science UniversityFellowship, Pediatric Endocrinology, 1998 - 2002
- University of Calgary Faculty of MedicineClass of 1994
Certifications & Licensure
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) Start of enrollment: 2006 Dec 01
Publications & Presentations
PubMed
- 4 citationsThe Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome.Jennifer L Miller, André Lacroix, Lynne M Bird, Ashley H Shoemaker, Andrea Haqq, Cheri L Deal, Kristie A Clark, Michael H Ames, Jeffrey G Suico, Amparo de la Peña, Car...> ;The Journal of Clinical Endocrinology and Metabolism. 2022 May 17
- 14 citationsUsing bioelectrical impedance analysis in children and adolescents: Pressing issues.Camila E. Orsso, Maria Cristina Gonzalez, Michael Johannes Maisch, Andrea M. Haqq, Carla M. Prado> ;European Journal of Clinical Nutrition. 2021 Oct 7
- 9 citationsComposition and Functions of the Gut Microbiome in Pediatric Obesity: Relationships with Markers of Insulin Resistance.Camila E. Orsso, Ye Peng, Edward C. Deehan, Qiming Tan, Catherine J. Field, Karen Madsen, Jens Walter, Carla M. Prado, Hein M. Tun, Andrea M. Haqq> ;Microorganisms. 2021 Jul 13
- Join now to see all
Press Mentions
- Personalised Treatment ‘More Effective’ When Treating Type 2 Diabetes and ObesityJune 1st, 2022
- Combination of Drugs for Obesity and Type 2 Diabetes May Be More Effective Than a Single TherapyMay 3rd, 2022
- Rhythm Pharmaceuticals Presents New Data at ESPE 2023September 23rd, 2023